Remimazolam may provide superior hemodynamic stability and faster postoperative recovery compared with propofol in adult cardiac surgery without compromising anesthetic efficacy or safety. Larger multicenter trials are needed to confirm these findings and define its long-term clinical benefits.

العنوان

Journal of Cardiothoracic and Vascular Anesthesia

الناشر

An-Najah National University

بلد الناشر

فلسطين

نوع المنشور

إلكتروني فقط

المجلد

--

السنة

2026

الصفحات

--